Organs-on-chip models for cardiovascular drug development

Cardiovasc Res. 2021 Nov 1;117(12):e164-e165. doi: 10.1093/cvr/cvab229.
No abstract available

Keywords: Drug development; Heart failure; Organs-on-chip; Stem cells; Tissue engineering.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cardiovascular Agents / adverse effects
  • Cardiovascular Agents / therapeutic use*
  • Cardiovascular Diseases / drug therapy*
  • Cardiovascular Diseases / metabolism
  • Cardiovascular Diseases / pathology
  • Cardiovascular Diseases / physiopathology
  • Cardiovascular System / drug effects*
  • Cardiovascular System / metabolism
  • Cardiovascular System / pathology
  • Cardiovascular System / physiopathology
  • Cells, Cultured
  • Drug Development / instrumentation*
  • High-Throughput Screening Assays
  • Humans
  • Lab-On-A-Chip Devices*
  • Microchip Analytical Procedures*
  • Phenotype
  • Stem Cells / drug effects*
  • Stem Cells / metabolism
  • Tissue Engineering

Substances

  • Cardiovascular Agents